{"id":28297,"date":"2020-07-13T09:54:54","date_gmt":"2020-07-13T09:54:54","guid":{"rendered":"https:\/\/www.healthbenefitstimes.com\/glossary\/?p=28297"},"modified":"2020-07-13T09:54:54","modified_gmt":"2020-07-13T09:54:54","slug":"narcotic-blocking-drugs-narcotic-antagonists","status":"publish","type":"post","link":"https:\/\/www.healthbenefitstimes.com\/glossary\/narcotic-blocking-drugs-narcotic-antagonists\/","title":{"rendered":"Narcotic-blocking drugs (narcotic antagonists)"},"content":{"rendered":"<p>Agents structurally similar to the opioids and probably occupying the same receptor sites in the central nervous system (CNS). In sufficient doses, they block the effects of opiate drugs by competing for the opioid receptor sites. If given after opiate dependence has developed, these agents will precipitate an acute abstinence syndrome.<\/p>\n<hr \/>\n<p>&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Agents structurally similar to the opioids and probably occupying the same receptor sites in the central nervous system (CNS). In sufficient doses, they block the effects of opiate drugs by competing for the opioid receptor sites. If given after opiate dependence has developed, these agents will precipitate an acute abstinence syndrome. &nbsp;<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[14],"tags":[],"class_list":["post-28297","post","type-post","status-publish","format-standard","hentry","category-n"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v21.1 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Narcotic-blocking drugs (narcotic antagonists) - Definition of Narcotic-blocking drugs (narcotic antagonists)<\/title>\n<meta name=\"description\" content=\"Agents structurally similar to the opioids and probably occupying the same receptor sites in the central nervous system (CNS). In sufficient doses, they block the effects of opiate drugs by competing for the opioid receptor sites. If given after opiate dependence has developed, these agents will precipitate an acute abstinence syndrome.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.healthbenefitstimes.com\/glossary\/narcotic-blocking-drugs-narcotic-antagonists\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Narcotic-blocking drugs (narcotic antagonists) - Definition of Narcotic-blocking drugs (narcotic antagonists)\" \/>\n<meta property=\"og:description\" content=\"Agents structurally similar to the opioids and probably occupying the same receptor sites in the central nervous system (CNS). In sufficient doses, they block the effects of opiate drugs by competing for the opioid receptor sites. If given after opiate dependence has developed, these agents will precipitate an acute abstinence syndrome.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.healthbenefitstimes.com\/glossary\/narcotic-blocking-drugs-narcotic-antagonists\/\" \/>\n<meta property=\"og:site_name\" content=\"Glossary\" \/>\n<meta property=\"article:published_time\" content=\"2020-07-13T09:54:54+00:00\" \/>\n<meta name=\"author\" content=\"Glossary\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Glossary\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/narcotic-blocking-drugs-narcotic-antagonists\/\",\"url\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/narcotic-blocking-drugs-narcotic-antagonists\/\",\"name\":\"Narcotic-blocking drugs (narcotic antagonists) - Definition of Narcotic-blocking drugs (narcotic antagonists)\",\"isPartOf\":{\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/#website\"},\"datePublished\":\"2020-07-13T09:54:54+00:00\",\"dateModified\":\"2020-07-13T09:54:54+00:00\",\"author\":{\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/#\/schema\/person\/ccfef987a4882e6356ae6d77d33e74c5\"},\"description\":\"Agents structurally similar to the opioids and probably occupying the same receptor sites in the central nervous system (CNS). In sufficient doses, they block the effects of opiate drugs by competing for the opioid receptor sites. If given after opiate dependence has developed, these agents will precipitate an acute abstinence syndrome.\",\"breadcrumb\":{\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/narcotic-blocking-drugs-narcotic-antagonists\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.healthbenefitstimes.com\/glossary\/narcotic-blocking-drugs-narcotic-antagonists\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/narcotic-blocking-drugs-narcotic-antagonists\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Narcotic-blocking drugs (narcotic antagonists)\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/#website\",\"url\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/\",\"name\":\"Glossary\",\"description\":\"Difinitions\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/#\/schema\/person\/ccfef987a4882e6356ae6d77d33e74c5\",\"name\":\"Glossary\",\"url\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/author\/adminglossary\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Narcotic-blocking drugs (narcotic antagonists) - Definition of Narcotic-blocking drugs (narcotic antagonists)","description":"Agents structurally similar to the opioids and probably occupying the same receptor sites in the central nervous system (CNS). In sufficient doses, they block the effects of opiate drugs by competing for the opioid receptor sites. If given after opiate dependence has developed, these agents will precipitate an acute abstinence syndrome.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.healthbenefitstimes.com\/glossary\/narcotic-blocking-drugs-narcotic-antagonists\/","og_locale":"en_US","og_type":"article","og_title":"Narcotic-blocking drugs (narcotic antagonists) - Definition of Narcotic-blocking drugs (narcotic antagonists)","og_description":"Agents structurally similar to the opioids and probably occupying the same receptor sites in the central nervous system (CNS). In sufficient doses, they block the effects of opiate drugs by competing for the opioid receptor sites. If given after opiate dependence has developed, these agents will precipitate an acute abstinence syndrome.","og_url":"https:\/\/www.healthbenefitstimes.com\/glossary\/narcotic-blocking-drugs-narcotic-antagonists\/","og_site_name":"Glossary","article_published_time":"2020-07-13T09:54:54+00:00","author":"Glossary","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Glossary"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/narcotic-blocking-drugs-narcotic-antagonists\/","url":"https:\/\/www.healthbenefitstimes.com\/glossary\/narcotic-blocking-drugs-narcotic-antagonists\/","name":"Narcotic-blocking drugs (narcotic antagonists) - Definition of Narcotic-blocking drugs (narcotic antagonists)","isPartOf":{"@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/#website"},"datePublished":"2020-07-13T09:54:54+00:00","dateModified":"2020-07-13T09:54:54+00:00","author":{"@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/#\/schema\/person\/ccfef987a4882e6356ae6d77d33e74c5"},"description":"Agents structurally similar to the opioids and probably occupying the same receptor sites in the central nervous system (CNS). In sufficient doses, they block the effects of opiate drugs by competing for the opioid receptor sites. If given after opiate dependence has developed, these agents will precipitate an acute abstinence syndrome.","breadcrumb":{"@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/narcotic-blocking-drugs-narcotic-antagonists\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.healthbenefitstimes.com\/glossary\/narcotic-blocking-drugs-narcotic-antagonists\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/narcotic-blocking-drugs-narcotic-antagonists\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.healthbenefitstimes.com\/glossary\/"},{"@type":"ListItem","position":2,"name":"Narcotic-blocking drugs (narcotic antagonists)"}]},{"@type":"WebSite","@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/#website","url":"https:\/\/www.healthbenefitstimes.com\/glossary\/","name":"Glossary","description":"Difinitions","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.healthbenefitstimes.com\/glossary\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/#\/schema\/person\/ccfef987a4882e6356ae6d77d33e74c5","name":"Glossary","url":"https:\/\/www.healthbenefitstimes.com\/glossary\/author\/adminglossary\/"}]}},"_links":{"self":[{"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/posts\/28297","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/comments?post=28297"}],"version-history":[{"count":1,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/posts\/28297\/revisions"}],"predecessor-version":[{"id":28298,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/posts\/28297\/revisions\/28298"}],"wp:attachment":[{"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/media?parent=28297"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/categories?post=28297"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/tags?post=28297"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}